{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:41:58Z","timestamp":1762875718092},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2528-3","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T03:00:10Z","timestamp":1445223610000},"page":"79-85","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome"],"prefix":"10.1007","volume":"95","author":[{"given":"Dolly","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Korgaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrakala","family":"Shanmukhaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babu Rao","family":"Vundinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"2528_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2350-11-163","volume":"11","author":"W Ma","year":"2010","unstructured":"Ma W, Kantarjian H, Zhang K, Zhang X, Wang X, Chen C, Donahue AC, Zhang Z, Yeh CH, O\u2019Brien S, Garcia-Manero G, Caporaso N, Landgren O, Albitar M (2010) Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome. BMC Med Genet 11:163","journal-title":"BMC Med Genet"},{"issue":"3","key":"2528_CR2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10245330410001701503","volume":"9","author":"D Rund","year":"2004","unstructured":"Rund D, Ben Yehuda D (2004) Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Hematology 9(3):179\u2013187","journal-title":"Hematology"},{"issue":"3","key":"2528_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/em.1033","volume":"37","author":"A Ronen","year":"2001","unstructured":"Ronen A, Glickman BW (2001) Human DNA repair genes. Environ Mol Mutagen 37(3):241\u2013283","journal-title":"Environ Mol Mutagen"},{"key":"2528_CR4","first-page":"213790","volume":"2014","author":"C Bsnescu","year":"2014","unstructured":"Bsnescu C, Trifa AP, Demian S, Lazar EB, Dima D, Duicu C, Dobreanu M (2014) Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia. Biomed Res Int 2014:213790. doi: 10.1155\/2014\/213790","journal-title":"Biomed Res Int"},{"key":"2528_CR5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/bgh166","volume":"25","author":"A Yamane","year":"2004","unstructured":"Yamane A, Kohno T, Ito K, Sunaga N, Aoki K et al (2004) Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 25:1689\u20131694","journal-title":"Carcinogenesis"},{"issue":"6665","key":"2528_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/34937","volume":"391","author":"FE Benson","year":"1998","unstructured":"Benson FE, Baumann P, West SC (1998) Synergistic actions of Rad51 and Rad52 in recombination and DNA repair. Nature 391(6665):401\u2013404","journal-title":"Nature"},{"issue":"1","key":"2528_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cancergencyto.2007.05.024","volume":"178","author":"L Jara","year":"2007","unstructured":"Jara L, Acevedo ML et al (2007) RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 178(1):65\u201369","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"2528_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/1055-9965.EPI-06-0562","volume":"16","author":"A Jakubowska","year":"2007","unstructured":"Jakubowska A, Gronwald J et al (2007) The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16(2):270\u2013275","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2528_CR9","first-page":"59","volume":"36","author":"JD Rowley","year":"1999","unstructured":"Rowley JD (1999) The role of chromosome translocations in leukemogenesis. Semin Hematol 36:59\u201372","journal-title":"Semin Hematol"},{"key":"2528_CR10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.leukres.2008.10.012","volume":"33","author":"E Fabiani","year":"2009","unstructured":"Fabiani E, D\u2019Al\u00f2 F, Scardocci A, Greco M, Di Ruscio A, Criscuolo M, Fianchi L, Pagano L, Hohaus S, Leone G, Voso MT (2009) Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 33:1068\u20131071","journal-title":"Leuk Res"},{"key":"2528_CR11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937\u2013951","journal-title":"Blood"},{"key":"2528_CR12","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.2741\/2380","volume":"12","author":"M Spry","year":"2007","unstructured":"Spry M, Pierce H (2007) DNA repair pathways and hereditary cancer susceptibility syndromes. Front Biosci 12:4191\u20134207","journal-title":"Front Biosci"},{"issue":"5","key":"2528_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00580-010-1120-4","volume":"21","author":"MS El-Din","year":"2012","unstructured":"El-Din MS, Raslan H, Abdel-Hamid S, Makhlouf M (2012) Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Comp Clin Pathol 21(5):505\u2013513","journal-title":"Comp Clin Pathol"},{"issue":"1","key":"2528_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2004.06.055","volume":"217","author":"T Joseph","year":"2005","unstructured":"Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR (2005) DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 217(1):17\u201324","journal-title":"Cancer Lett"},{"issue":"3","key":"2528_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/1607845412Y.0000000040","volume":"18","author":"S Annamaneni","year":"2013","unstructured":"Annamaneni S, Gorre M, Kagita S, Addepalli K, Digumarti RR, Satti V, Battini MR (2013) Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India. Hematology 18(3):163\u2013168","journal-title":"Hematology"},{"key":"2528_CR16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12032-014-0174-6","volume":"31","author":"MB Aktuglu","year":"2014","unstructured":"Aktuglu MB, Ayer M, Bireller ES, Rencuzogullari C, Acik H, Karaali Z, Alioglu T, Yigit N, Velet M, Atalay E, Ure OS, Cakmakoglu B (2014) Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population. Med Oncol 31:174","journal-title":"Med Oncol"},{"key":"2528_CR17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.leukres.2010.12.001","volume":"35","author":"L L","year":"2011","unstructured":"L L, Yang L, Zhang Y, Xu Z, Qin T, Hao Y, Xiao Z (2011) Detoxification and DNA repair genes polymorphisms and susceptibility of primary myelodysplastic syndromes in Chinese population. Leuk Res 35:762\u2013765","journal-title":"Leuk Res"},{"key":"2528_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-9","volume":"6","author":"M Belickova","year":"2013","unstructured":"Belickova M, Merkerova MD, Stara E, Vesela J, Sponerova D, Mikulenkova D, Brdicka R, Neuwirtova R, Jonasova A, Cermak J (2013) DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. J Hematol Oncol 6:1\u20136","journal-title":"J Hematol Oncol"},{"issue":"10","key":"2528_CR19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ajh.21255","volume":"83","author":"LM Baumann Kreuziger","year":"2008","unstructured":"Baumann Kreuziger LM, Steensma DP (2008) RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes. Am J Hematol 83(10):822\u2013823","journal-title":"Am J Hematol"},{"key":"2528_CR20","first-page":"7430","volume":"61","author":"H Seker","year":"2001","unstructured":"Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M, Grossman L, Haris CC (2001) Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype. Cancer Res 61:7430\u20137434","journal-title":"Cancer Res"},{"key":"2528_CR21","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2002-04-1152","volume":"100","author":"C Seedhouse","year":"2002","unstructured":"Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E (2002) The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 100:3761\u20133766","journal-title":"Blood"},{"key":"2528_CR22","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2004-06-2161","volume":"104","author":"JM Allan","year":"2004","unstructured":"Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP (2004) Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 104:3872\u20133877","journal-title":"Blood"},{"key":"2528_CR23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2005-06-2305","volume":"107","author":"PA Mehta","year":"2006","unstructured":"Mehta PA, Alonzo TA, Gerbing RB, Elliott JS, Wilke TA, Kennedy RJ, Ross JA, Perentesis JP, Lange BJ, Davies SM (2006) XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children\u2019s Oncology Group report. Blood 107:39\u201345","journal-title":"Blood"},{"key":"2528_CR24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/35036399","volume":"2","author":"CS Griffin","year":"2000","unstructured":"Griffin CS, Simpson PJ, Wilson CR, Thacker J (2000) Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol 2:757\u2013761","journal-title":"Nat Cell Biol"},{"key":"2528_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0921-8777(99)00010-5","volume":"434","author":"X Cui","year":"1999","unstructured":"Cui X, Brenneman M, Meyne J, Oshimura M, Goodwin EH, Chen DJ (1999) The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res 434:75\u201388","journal-title":"Mutat Res"},{"key":"2528_CR26","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1093\/emboj\/20.22.6530","volume":"20","author":"A-E Vidal","year":"2001","unstructured":"Vidal A-E, Boiteux S, Hickson I-D, Radicella J-P (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 20:6530\u20136539","journal-title":"EMBO J"},{"key":"2528_CR27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-200005000-00010","volume":"11","author":"J Bjork","year":"2000","unstructured":"Bjork J, Albin M, Mauritzson N, Stromberg U, Johannson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11:285\u2013291","journal-title":"Epidemiology"},{"issue":"1","key":"2528_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2009.08.006","volume":"34","author":"Y Du","year":"2010","unstructured":"Du Y, Fryzek J, Sekeres MA, Taioli E (2010) Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res 34(1):1\u20135","journal-title":"Leuk Res"},{"issue":"4","key":"2528_CR29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10552-011-9735-6","volume":"22","author":"X Ma","year":"2011","unstructured":"Ma X, Wang R, Galili N, Mayne ST, Wang SA, Yu H, Raza A (2011) Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes. Cancer Causes Control 22(4):623\u2013629","journal-title":"Cancer Causes Control"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2528-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2528-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:02Z","timestamp":1559037002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2528-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2528"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2528-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}